4.4 out of 5 stars
(919 Ratings)
Qualio is a purpose-built quality and compliance platform for life sciences companies operating in complex, high-stakes regulatory environments. Medical device, SaMD, biotech, and pharma teams use Qualio to replace fragmented eQMS tools, spreadsheets, and consultant-driven audits with a single, validated system that delivers continuous audit and inspection readiness.
Qualio combines a modern eQMS with Compliance Intelligence—an AI-driven layer that continuously evaluates how well real operating data aligns with regulatory requirements. Instead of treating audits as one-off events, teams gain always-on visibility into compliance coverage, risk exposure, and readiness across FDA, ISO, EU MDR, GxP, and software-intensive standards.
Core quality workflows—document control, training, CAPA, change management, supplier quality, and design controls—are directly connected to regulatory obligations and objective evidence. Deep integrations with Jira, Azure DevOps, GitHub, TestRail, and Salesforce automatically capture proof from development and operational systems, eliminating manual evidence gathering and reducing compliance drag on engineering teams.
Compliance Intelligence runs multi-standard gap analysis in under an hour, flags emerging risks before they become findings or 483s, and maps reusable evidence across frameworks to accelerate submissions and market expansion. All insights are explainable and traceable back to specific clauses and internal policies, supporting validation and audit expectations.
The result: audit readiness in weeks instead of months, fewer fire drills, faster launches, and lower long-term compliance cost. Qualio turns compliance from a reactive burden into a predictable, scalable system.
Learn more about Qualio
4.5 out of 5 stars
(29 Ratings)
Gushwork's AI agents enhance your business's visibility to potential buyers through AI search, Google, and various paid channels, ultimately converting that interest into marketing-qualified leads with a comprehensive service. Operating seamlessly in the background, these agents familiarize themselves with your business and target audience, analyze the search behavior of potential buyers before they make contact, and identify where competitors are capturing attention instead of your brand. They then create content tailored to those searches, establish the necessary backlinks and citations that AI algorithms depend on, and continuously refine your pages in response to evolving AI-driven queries. Every visitor is meticulously tracked while spam is eliminated, ensuring that your team is only informed about the leads that truly matter. With over 1,000 customers, Gushwork has successfully generated more than $10 million in potential revenue for its clients, demonstrating its effectiveness in driving business growth. This innovative approach not only streamlines lead generation but also provides valuable insights into market dynamics.
Learn more about Gushwork
Compier Literature Screening
Compier Literature Screening is an AI-powered platform aimed at helping pharmacovigilance experts streamline the process of reviewing abstracts, full texts, and translated articles to uncover pertinent information about patients, authors, events, products, and safety-related data. This innovative platform seamlessly connects with various online biomedical databases, including Medline, and allows users to upload literature records in bulk from multiple sources like Embase, conference presentations, and PDF journals. It conducts automated duplicate checks for every literature search and employs validated AI models for the automatic screening and annotation of key entities. Users have the flexibility to set up scalable literature screening workflows that meet their unique needs and comply with international regulations. The system enhances collaboration with external vendors to secure full texts and comes equipped with translation capabilities. Additionally, it integrates smoothly with safety systems, such as Oracle Argus Safety, to share articles relevant to Individual Case Safety Reports (ICSRs), thereby ensuring comprehensive safety monitoring. The platform ultimately seeks to improve the overall efficiency and accuracy of pharmacovigilance activities.
Learn more about Compier Literature Screening
PubMed
PubMed® is an extensive repository featuring over 35 million citations related to biomedical literature, sourced from MEDLINE, life science journals, and various online books. Many of these citations provide links to full-text articles, which can be accessed through PubMed Central and the websites of publishers. This invaluable resource is designed to facilitate the search and retrieval of literature in the biomedical and life sciences, ultimately aiming to enhance health on both a global and individual level. Although the PubMed database does not host full-text journal articles directly, it often includes hyperlinks to such content when it is accessible from other platforms, such as the publisher's site or PubMed Central (PMC). The citations within PubMed primarily originate from fields related to biomedicine and health, as well as associated disciplines that encompass life sciences, behavioral sciences, chemical sciences, and bioengineering. A significant part of PubMed is made up of MEDLINE, which contains citations from journals that have been selectively included for its collection. Researchers and healthcare professionals frequently utilize this platform to stay informed on the latest developments and findings in medical research.
Learn more about PubMed